Biomolecular Detection and Quantification journal launch
27 Mar 2015
LGC scientists are behind a new journal dedicated to championing excellence in molecular study design, measurement, data analysis and reporting, which has officially launched this week.
Biomolecular Detection and Quantification
(BDQ) launched at the Advanced Molecular Diagnostics for Biomarker Discovery
conference in Germany this week.
Jim Huggett, Principal Scientist in the Molecular Biology team at LGC, was at the launch in his role as Managing Editor of the journal, along with Stephen Bustin, Professor of Molecular Medicine, from Anglia Ruskin University, who is the journal's Editor in Chief, and Justin O'Grady, from Norwich Medical School, University of East Anglia, UK who is also a Managing Editor.
BDQ was established by a group of scientists based on their experience developing and publishing the Minimum Information for Publication of Quantitative Real-Time (and Digital) PCR Experiments (the MIQE and digital MIQE guidelines). The deliberately broad scope of the journal covers clinical areas such as cancer, epigenetics, metagenomics, and infectious diseases as well as non clinical subjects including environmental analysis, microbiology and food science.
The journal features an international team of editors who are experts in qualitative and quantitative molecular methodologies, with many from National Measurement Institutes, including LGC's Carole Foy, Principal Scientist, Molecular Biology.
Talking at the launch, Jim Huggett said: “BDQ revolves around the common theme of promoting excellence in molecular measurement and its data analysis. It will serve as a repository for sharing key findings across what may otherwise be disparate specialities.
“The journal has an international audience and we particularly welcome submissions from younger scholars and researchers and those from developing countries.”
For more information on BDQ, visit the Elsevier website